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Neisseria gonorrhoeae causes gonorrhea, a sexually transmitted infection characterized by inflammation of the cervix or urethra.
However, a significant subset of patients with N. gonorrhoeae remain asymptomatic, without evidence of localized inflamma-
tion. Inflammatory responses to N. gonorrhoeae are generated by host innate immune recognition of N. gonorrhoeae by several
innate immune signaling pathways, including lipooligosaccharide (LOS) and other pathogen-derived molecules through activa-
tion of innate immune signaling systems, including toll-like receptor 4 (TLR4) and the interleukin-1 (IL-1) processing com-
plex known as the inflammasome. The lipooligosaccharide of N. gonorrhoeae has a hexa-acylated lipid A. N. gonorrhoeae strains
that carry an inactivated msbB (also known as lpxL1) gene produce a penta-acylated lipid A and exhibit reduced biofilm forma-
tion, survival in epithelial cells, and induction of epithelial cell inflammatory signaling. We now show that msbB-deficient N.
gonorrhoeae induces less inflammatory signaling in human monocytic cell lines and murine macrophages than the parent organ-
ism. The penta-acylated LOS exhibits reduced toll-like receptor 4 signaling but does not affect N. gonorrhoeae-mediated activa-
tion of the inflammasome. We demonstrate that N. gonorrhoeae msbB is dispensable for initiating and maintaining infection in
a murine model of gonorrhea. Interestingly, infection with msbB-deficient N. gonorrhoeae is associated with less localized in-
flammation. Combined, these data suggest that TLR4-mediated recognition of N. gonorrhoeae LOS plays an important role in
the pathogenesis of symptomatic gonorrhea infection and that alterations in lipid A biosynthesis may play a role in determining
symptomatic and asymptomatic infections.
Lipopolysaccharide (LPS) is an importance virulence factor inGram-negative bacteria. LPS consists of a complex polysac-
charide attached to a core saccharide consisting of 3-deoxy-D-
mannooctulosonic acid (keto-deoxyoctulosonate [KDO]) and an
acylated diglucosamine moiety known as lipid A. Neisseria species
(as well as some other commensal and pathogenic bacteria) make
LPS with a truncated polysaccharide structure, which is termed
lipooligosaccharide (LOS). LOS is a potent mediator of inflamma-
tory signaling and is known to activate several host innate immune
signaling systems, including toll-like receptor 4 (TLR4) through the
lipid A molecule, C-lectin receptors (particularly MGL and DC-
SIGN) through the oligosaccharide structure, and the caspase-1 acti-
vating complex known as the NLRP3-inflammasome through mech-
anisms yet to be determined (1–4).
Lipid A synthesis is largely carried out by a highly conserved set
of enzymatic steps that include the acylation of glucosamine-
based precursors followed by condensation of these acylated glu-
cosamine structures into the tetra-acylated disaccharide backbone
that is the core structure of lipid A. This core is further decorated
by the addition of two KDOs (2) and a variety of other additional
modifications of the lipidated disaccharide (5). Lipid A is known
to influence virulence of numerous bacterial pathogens and has
been studied well in Neisseria meningitidis. Deletion of lpxA, the
acyltransferase that catalyzes the initial lipidation of UDP-gluco-
samine, in N. meningitidis leads to a bacterium that does not
generate LOS (6). N. meningitidis without LOS induces less in-
flammatory signaling through TLR4 than the wild-type N. men-
ingitidis, but the two strains have been found to be roughly equal
in virulence in a murine sepsis model (7). N. meningitidis also has
two lipid A acyltransferases (lpxL1 and lpxL2), which are respon-
sible for adding secondary acyl chains to lipid A. Deletion of lpxL1
(msbB) and lpxL2 leads to N. meningitidis with penta- or tetra-
acylated lipid A, respectively. Both penta- and tetra-acylated LOS
demonstrate reduced potency in the activation of human TLR4 (8,
9). However, an lpxL2 mutant demonstrates increased virulence,
while an lpxL1 mutant has dramatically reduced virulence in a
mouse model of meningococcal sepsis (10). Interestingly, natu-
rally occurring mutations in lpxL1 have been discovered in 13%
of all strains of N. meningitidis recovered from patients with inva-
sive N. meningitidis infection (11, 12). Patients with these strains
had a significantly reduced severity of thrombocytopenia and pe-
techial rash and a nonsignificant reduction in hypotension and
septic shock, suggestive of reduced virulence in human infection
as well (12). Further, N. meningitidis strains carrying lpxL1 muta-
tions make up the majority of strains isolated from patients with
chronic meningococcemia, which presents with a prolonged dis-
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ease course that lacks the symptoms of severe septic shock-associ-
ated acute meningococcal infections (13).
The phenotype of a Neisseria gonorrhoeae strain with disrupted
msbB has also been examined (14–16). Lipid A from the LOS of
these mutant bacteria is penta-acylated (14). The bacteria show
reduced capacity to produce biofilms and are more susceptible to
intracellular killing by epithelial cells (14–16). They also induce
less production of the cytokine interleukin-8 (IL-8) from epithe-
lial cells (15). While epithelial cells are the initial targets of N.
gonorrhoeae in early infection, infected sites are later infiltrated by
host phagocytic cells, which largely make up the inflammatory
exudates characteristic of infection with N. gonorrhoeae. We
sought to further investigate the role of lipid A acylation in inflam-
matory signaling during gonococcal infection by studying the in-
flammatory signaling in monocyte-derived cells and the patho-
genesis of infection using a well-established murine model of
gonococcal infection (17).
MATERIALS AND METHODS
Ethics statement. Experiments describing the generation of bone mar-
row-derived immune cells and the use of the murine model of gonorrhea
were conducted in accordance with National Institutes of Health guide-
lines for the care and use of laboratory animals under a protocol approved
by the Institutional Animal Care and Use Committee (IACUC) of the
University of North Carolina at Chapel Hill (UNC IACUC protocols 09-
229.0 and 12-207.0).
N. gonorrhoeae strains and culture. N. gonorrhoeae strain 1291, iso-
genic msbB-deficient strain (designated 1291-msbB in this article; rele-
vant genotype, msbB::kanr), and the 1291-msbB strain complemented in
trans by insertion of the spectinomycin resistance marker and msbB gene
into the proB gene (designated 1291-msbB;msbB in this article; relevant
genotype, msbB::kanr proB::spcrmsbB) have all been described previ-
ously (14, 16). Piliated (pil), opaque (opa) populations of each strain
were cultured and prepared to inoculate immune cell cultures or mice as
previously described (4). Briefly, the strains were grown on Difco GC
medium base (GCB; Becton Dickinson, Sparks, MD) agar plates over-
night (16 h to 18 h) at 37°C in 5% CO2, and the bacteria were harvested
using sterile cotton swabs and transferred into complete cell culture media
(for cell culture experiments) or phosphate-buffered saline (PBS) (for
murine inoculation). The quantity of CFU in the suspensions was esti-
mated by measuring the optical density at 600 nm (OD600), and the actual
administered doses were determined by colony counting after plating
serial dilutions of the suspended N. gonorrhoeae cells.
Culture of THP1 monocytic cells and BMDM. The human mono-
cytic cell line THP1 was propagated in RPMI 1640 plus 10% fetal bovine
serum (FBS) as previously described (4). Mouse bone marrow-derived
macrophage (BMDM) were prepared from 8- to 12-week-old C57BL/6
mice (Jackson Laboratories, Bar Harbor, ME) (18). Femurs and tibiae
were harvested from euthanized mice, and the marrow was flushed from
each bone using RPMI 1640 (Invitrogen). The marrow cells were dis-
persed, washed, and cultured in cytokine-supplemented medium. To
generate BMDM, the bone marrow cells were cultured in medium con-
taining 30% L929 conditioned medium as a source of granulocyte colony-
stimulating factor (G-CSF). At day 7, the BMDM were collected and ad-
justed to a concentration of 1  106 cells/ml and plated for further
treatment.
Murine N. gonorrhoeae infection. The protocol for murine vaginal
infection with N. gonorrhoeae was utilized as described by Jerse et al. (17).
Basically, 4- to 6-week-old female BALB/c (Jackson laboratory) mice in
proestrus stage were treated with water-soluble -estradiol (Sigma) and
streptomycin, vancomycin, and trimethoprim (Sigma) on day 2, as de-
scribed. On day zero, the mouse vagina was inoculated with an estimated
106 CFU of the indicated strain of N. gonorrhoeae suspended in PBS. For
the subsequent 10 days, vaginal swabs were collected from each mouse in
the morning. The population of N. gonorrhoeae was determined by plating
of serial dilutions of the suspended material obtained from the vaginal
swab on GCB agar supplemented with vancomycin, colistin, nystatin,
trimethoprim, and streptomycin (VCNTS-GCB). The quantity of vaginal
neutrophils as a fraction of recovered nucleated cells was determined each
day by differential counting of the Giemsa-stained smears from the vagi-
nal swab. Inflammatory gene expression was monitored as described by
Packiam et al. using the mouse antibacterial response RT2 Profiler PCR
array (SA Bioscience, Frederick, MD) (19, 20). Vaginal lavage was per-
formed after the vaginal swab collection was carried out on the fourth day
of infection by repeated flushing (20 times) of the vaginal cavity with 50 l
of PBS. Cells and debris from the lavage were removed by centrifugation at
700  g for 10 min and saved for RNA extraction, and the supernatant was
processed for cytokine measurement. Competitive infection experiments
were carried out as an adaption of that published by Warner et al. (21). An
inoculum was prepared containing roughly a 1:1 ratio of two N. gonor-
rhoeae strains (strains 1291 and 1291-msbB or 1291-msbB;msbB).
Vaginal swabs were obtained every other day, and the quantity of viable N.
gonorrhoeae organisms was determined by plating serial dilutions from
resuspended swabs on VCNTS-GCB agar. The ratio of each strain was
then determined by picking 48 individual colonies from the VCNTS-GCB
plates and replica plating these under appropriate antibiotic selection.
Measurement of cytokines, chemokines, and Caspase-1 activation.
IL-1, tumor necrosis factor alpha (TNF-	), and macrophage inflamma-
tory protein 1 alpha (MIP-1	) secreted from THP1 or BMDM were mea-
sured by enzyme-linked immunosorbent assay (ELISA) according to the
manufacturers’ protocols: the MIP-1	 ELISA kit was from R&D system
(Minneapolis, MN), and the IL-1 and TNF-	 kits were from BD biosci-
ences (San Diego, CA). IL-1 and TNF-	 from BMDM were measured
using AlphaLisa cytokine detection kits from PerkinElmer (Waltham,
MA). The cytokines and chemokines from vaginal lavage supernatants
were measured with the Bio-plex system (Bio-Rad, Hercules, CA) in the
Duke Human Vaccine Institute Immune Reconstitute and Biomarker Fa-
cility. Caspase-1 activation was assessed by immunoblot analysis using
antibodies directed to the p10 subunit of Caspase-1 as described by Cra-
ven et al. (22).
Treatment of HEK-Blue-hTLR4 cells, THP-1 cells, and BMDM with
LOS or N. gonorrhoeae. Purified LOS from N. gonorrhoeae strains 1291
and 1291-msbB were prepared as previously described (15). HEK-Blue-
hTLR4 cells (Invivogen) were treated with the indicated concentration of
purified LOS for 16 h, and secreted alkaline phosphatase (SEAP) was
assayed using a colorimetric assay (quanti-Blue; Invivogen) according to
the manufacturer’s protocol. To determine the level of LOS-induced
SEAP activity, the level of SEAP activity was measured in cells that were
not treated with LOS, and this basal level of SEAP activity was subtracted
from the relative SEAP activity measured in each treated sample. THP1
cells (and BMDM) were treated with LOS from N. gonorrhoeae, and cell
culture supernatants were harvested for cytokine measurements as previ-
ously described (4).
RNA isolation and qRT-PCR from murine vaginal washes. Cell-con-
taining pellets from vaginal lavage samples obtained from infected mice
were stored at 80°C, and RNA was isolated using the RNeasy isolation
kit (Qiagen) according to the manufacturer’s protocol. The isolated RNA
was DNase treated to remove residual DNA contamination, and total
RNA was then used in a quantitative reverse transcription-PCR (qRT-
PCR) assay to measure inflammation-related RNA expression on a mouse
antibacterial response RT2 Profiler PCR array (SA Bioscience, Frederick,
MD) according to the manufacturer’s protocol (20).
Statistical analysis. Prism Graphpad was used for statistical analysis.
Student’s t test was used to compare groups when experimental design
dictated two groups. Analysis of variance (ANOVA) was used in conjunc-
tion with a post hoc Bonferroni test for multiple comparisons to analyze
experiments with more than two test groups. P values of 
0.05 were
considered significant.
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RESULTS
In order to determine whether N. gonorrhoeae msbB influenced
the level of inflammatory cytokine response in phagocytic cells,
THP1 cells were treated with increasing doses of N. gonorrhoeae
strain 1291, strain 1291-msbB, or the complemented mutant,
1291-msbB;msbB. The secretion levels of IL-1, TNF-	, and
MIP-1	 were examined in the culture supernatants of these bac-
terium-exposed THP1 cells (Fig. 1A to C). The 1291-msbB strain
caused less secretion of each of these cytokines than the parental
1291 strain when a low multiplicity of infection (MOI; the ratio of
bacteria to cells) was used. At higher MOI, the difference between
the parental strain and the msbB-deficient strain was lost, suggest-
ing that mutant bacteria had reduced potency in cytokine induc-
tion that could be overcome by sufficiently high inoculation. Al-
ternatively, and not exclusive of a simple reduction of signaling
potency in a single innate immune signaling pathway, higher
doses of N. gonorrhoeae might lead to the activation of additional
inflammatory signaling pathways that could compensate for the
pathway or pathways affected by loss of the msbB gene. The re-
duced potency in induction of host cytokine production was re-
versed in the complemented msbB mutant strain. Similar effects
on IL-1 secretion and TNF-	 secretion were observed when pri-
mary bone marrow-derived macrophages from mice were treated
with these N. gonorrhoeae strains (Fig. 1D and E). This indicated
that the effects on host inflammatory signaling by disruption of
msbB were similar between species. When isolated lipooligosac-
charide from the parental and 1291-msbB strains was used to
stimulate THP1 cells, this penta-acylated LOS showed a 3-log
decrease in its potency in inducing TNF-	 (Fig. 2). These data
demonstrate that lipid A hexa-acylation plays an important role in
induction of host inflammatory cytokine production by N. gonor-
rhoeae.
Two signaling pathways are known to contribute to host pro-
duction of IL-1. First, activation of TLR4 leads to production of
pro-IL-1 as well as the inflammasome component NLRP3 (23).
NLRP3 is also nontranscriptionally primed for activation in re-
sponse to TLR4 stimulation through regulated deubiquitination
(24). Second, NLRP3 inflammasome activation and subsequent












































































































FIG 1 N. gonorrhoeae msbB controls induction of host inflammatory cytokines in human-derived cells and mouse primary macrophages. (A to C) THP1 cells
were treated with the indicated doses of N. gonorrhoeae (MOI, 0.1,1, or 10) for 4 h, and culture supernatants were collected. Secreted IL-1 (A), TNF-	 (B), and
MIP-1	 (C) were measured with ELISA. (D and E) Mouse bone marrow-derived macrophages were generated and exposed to the indicated doses (MOI) of the
indicated N. gonorrhoeae strains as described in Materials and Methods. Secreted IL-1 (D) and TNF-	 (E) were measured in cell culture supernatants as
described in Materials and Methods. The mean values  standard deviations from five (A, B, C) or three (D, E) independent experiments are plotted. Statistical
analysis with two-way ANOVA and Bonferroni’s post hoc test for multiple comparisons was carried out; *, P 
 0.05; **, P 































FIG 2 N. gonorrhoeae msbB alters the host cytokine response through effects
on purified LOS. LOS was isolated from N. gonorrhoeae strains 1291 and 1291-
msbB. THP1 cells were treated with the indicated doses of LOS (1 ng/ml to
1,000 ng/ml) for 4 h, and secreted TNF-	 was measured as described in Ma-
terials and Methods. Results depicted are means of triplicate measurements in
a single experiment and are representative of at least three independent exper-
iments.
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that can include activation of the purogenic receptor P2X7 by
extracellular ATP, disruption of phagocytic vacuoles, or insertion
of pore-forming toxins into the cell membrane. The “second sig-
nals” that are provided by N. gonorrhoeae to induce NLRP3 acti-
vation have yet to be determined. The ability of N. gonorrhoeae
1291-msbB to activate these signaling pathways was assessed.
First, bone marrow macrophages were primed with LOS derived
from either 1291 or 1291-msbB and subsequently treated with
ATP to induce inflammasome activation. As previously noted for
TNF-	 secretion, the 1291-msbB LOS demonstrated at least a
3-log decrease in its potency in contributing to IL-1 secretion
(Fig. 3A). Isolated LOS from N. gonorrhoeae 1291 and 1291-
msbB were tested for the ability to stimulate TLR using a TLR4
reporter cell line that expresses human TLR4/MD-2 and an NF-
B-responsive secreted alkaline phosphatase. LOS from the pa-
rental N. gonorrhoeae strain caused the induction of alkaline phos-
phatase activity in the 10- to 100-pg/ml concentration range,
while isolated penta-acylated LOS from the msbB mutant failed to
activate TLR4 at even 1,000 pg/ml (Fig. 3B). In a second set of
experiments, Caspase-1 activation was examined in THP1 cells
treated with each N. gonorrhoeae strain using immunoblotting to
detect the p10 subunit of activated Caspase-1. While TLR4 was
differentially activated by 1291 and 1291-msbB, Caspase-1 acti-
vation was equally activated by each strain (Fig. 3C to E). Conse-
quently, the hexa-acyl lipid A appears to exert the majority of its
effect on host inflammatory signaling, including IL-1 secretion,
through effects on TLR4 activation.
To test the role of lipid A hexa-acylation in gonococcal infec-
tion, a murine model of vaginal N. gonorrhoeae infection was used.
We first sought to determine whether msbB deficiency led to a
relative fitness defect in N. gonorrhoeae by carrying out a compet-
itive infection. The N. gonorrhoeae strain with a disrupted msbB
gene had a profound fitness deficit compared to the parental strain
or the isogenic strain with complemented msbB expression (Fig.
4A and B). Though 1291-msbB has previously been reported to
have no growth deficit in in vitro culture compared to its isogenic
parental strain, 1291, we also confirmed that both strains main-
tained themselves in equal proportion when grown as mixed cul-
ture in vitro (data not shown) (14). We also sought to determine
the effect of gonococcal msbB on the pathogenesis of infection by
studying BALB/c mice inoculated with single N. gonorrhoeae
strains, either 1291, 1291-msbB, or 1291-msbB;msbB. The
number of N. gonorrhoeae colonies recovered from daily vaginal
swabs of each infected mouse was assessed. Despite the notable
fitness defect caused by deletion of msbB in competitive infections,
no difference between persistence of infection was noted between
any of the tested strains (Fig. 4C). In the mice with persistent
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FIG 3 N. gonorrhoeae msbB influences TLR4 activation but not NLRP3 inflammasome activation in host cells. (A) THP1 cells were treated with the indicated
doses of LOS (1 ng/ml to 1,000 ng/ml) for 3 h, 5 mM ATP was added for an additional hour to induce inflammasome activation, and secreted IL-1 was measured
as described in Materials and Methods. (B) The indicated concentrations of purified LOS from N. gonorrhoeae strains 1291 and 1291-msbB were incubated with
HEK-blue TLR4 cells for 24 h, and secreted alkaline phosphatase activity was measured as described in Materials and Methods. (C to E) THP-1 cells were treated
with the indicated doses of N. gonorrhoeae strains 1291 and 1291-msbB as described for Fig. 1. Cell pellets were harvested, and cell lysates were generated and
analyzed by immunoblot analysis with antibodies directed to Caspase-1 p10 subunit and actin. Representative results are shown in panel C. Densitometry
was performed on three independent experiments, and the mean band density normalized to the untreated sample is reported for activated Caspase-1 (C)
and actin (D).
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rhoeae colonies recovered was noted between these strains except
on the first day postinoculation (Fig. 4D). Despite having no sig-
nificant difference in the quantity of live bacteria in the CFU cul-
tured from the initial inoculum compared to the parental strain,
1291, the 1291-msbB strain exhibited a significant 1.5-log reduc-
tion in recovered N. gonorrhoeae on day 1 (Fig. 4D and E). The
1291-msbB strain also demonstrated a similar 1.5-fold reduction
in the first-day N. gonorrhoeae recovery compared to N. gonor-
rhoeae in which msbB expression was complemented, though the
average inoculum for the complemented strain was slightly higher
than for the mutant strain (Fig. 4E). These data suggested that
while msbB is not required for N. gonorrhoeae to initiate or persist
in the genital tract, it does impart a competitive advantage in vag-
inal infection compared to N. gonorrhoeae isolates that lack an
active msbB gene.
In the murine model of gonococcal infection, the mouse va-
gina develops a neutrophilic influx several days after inoculation
(17). This is not unlike the onset of cervical or urethral inflamma-
tion that accompanies symptomatic gonococcal infection in hu-
mans. We found that on most days after inoculation the quantity
of vaginal neutrophils was lower in mice infected with 1291-
msbB; however, this finding did not meet statistical significance
(Fig. 5A). We also quantitated the total neutrophil influx over the
course of the infection by calculating the area under the curve for
the percentage of vaginal neutrophils plotted against time for each
individual infected mouse and designated this area under the
curve the neutrophil flux AUC. The mean neutrophil influx AUC
for mice infected with the parental strain was significantly greater
than the mean neutrophil influx AUC found in mice inoculated
with PBS, while the mean neutrophil influx AUC of the mice in-
fected with the 1291-msbB strain was not significantly different
from that of PBS-treated mice (Fig. 5B). To confirm that the lack


























































































































































FIG 4 N. gonorrhoeae msbB is not required to establish or maintain vaginal infection in the murine model of N. gonorrhoeae but influences fitness in competitive
infection. Four- to 7-week-old BALB/c mice were infected with N. gonorrhoeae strains 1291, 1291-msbB, and 1291-msbB;msbB as indicated. (A and B) Mice
were inoculated with a combination of 1291 and 1291-msbB (A) or 1291-msbB and 1291-msbB;msbB (B), and the relative quantity of each strain is plotted
for each mouse on the indicated day postinoculation. The hashed lines indicate the limit of detection for the ratio of bacteria (48 colonies from each mouse were
replica plated to determine the strain of each colony). The solid black line indicates the ratio of the strains in the inoculum. The plot is representative of two
independent experiments. (C and D) Mice were infected with single N. gonorrhoeae strains 1291 (n  22), 1291-msbB (n  24), and 1291-msbB;msbB (n 
17) as indicated, and persistence of infection (C) and quantity (D) of N. gonorrhoeae present on vaginal swabs were determined as described in Materials and
Methods. Plots show combined results from 4 independent experimental infections. Vaginal N. gonorrhoeae burdens were analyzed using two-way ANOVA, and
Bonferroni’s post hoc test for multiple comparisons was carried out; ***, P 
 0.01 and P  0.005; N.S., not significant. The inoculum dose for each mouse in all
experiments is plotted in panel E.
Zhou et al.
188 iai.asm.org Infection and Immunity
of neutrophil influx during infection with 1291-msbB was attrib-
utable to the loss of msbB, cohorts of mice were inoculated with
PBS, 1291, 1291-msbB, or 1291-msbB;msbB. The induction
of vaginal neutrophil influx was restored (Fig. 5C). Vaginal in-
flammation was also characterized by assessing mRNA expression
of genes involved in host antimicrobial response and levels of in-
flammatory cytokines present in vaginal lavage fluid during infec-
tion. The inflammatory cytokines TNF-	, MIP-1	, and IL-1
were measured in vaginal lavage fluid from mice infected with
each strain of N. gonorrhoeae on day 4 postinoculation. Vaginal
TNF-	 and MIP-1	 were both induced by infection with the wild
type and the complemented msbB mutant but not by infection
with strain 1291-msbB (Fig. 6A and B). A similar trend was noted
in vaginal IL-1, although the majority of mice did not have de-
tectable quantities of IL-1 in the vaginal lavage at day 4 (Fig. 6C).
Limitations in the quantity of cells, and consequently mRNA, re-
covered from the vaginal lavage fluid and a relatively low abun-
dance of expression of many of the host antimicrobial response
genes resulted in the inability to fully evaluate the expression of
many of these genes during infection (data not shown). However,
Cxcl1 and Naip1 were both found to be diminished in their ex-
pression in mice infected with the 1291-msbB mutant strain
compared to those infected with wild-type 1291, while those in-
fected with 1291-msbB;msbB were not significantly different
from those infected with 1291 (Fig. 6D).
DISCUSSION
Our findings suggest that the state of lipid A acylation status can
play a significant role in the pathogenesis of N. gonorrhoeae infection.
Deletion of the msbB gene resulted in three primary phenotypic
changes related to pathogenesis, the reduction of TLR4-induced in-
flammatory signaling in vitro, reduced vaginal inflammation during
infection, and a reduced fitness in competitive infections in the mu-
rine gonorrhea model.
Previous work studying this strain of N. gonorrhoeae with a
disrupted msbB gene has demonstrated that both live bacteria with
a disrupted msbB gene and LOS isolated from these bacteria have
diminished capacity to induce IL-6 and IL-8 production by epi-
thelial cells (15). Epithelial cells incubated with N. meningitidis
carrying a deletion of lpxL1 (also msbB) secreted less TNF-	 than
cells treated with the parental wild-type strain (8, 9). Further stud-
ies demonstrated that penta-acylated lipid A-containing N. men-
ingitidis LOS (from the lpxL1 strain) has reduced potency in
activation of murine and hamster TLR4 while actually acting as a
TLR4 antagonist or partial agonist for human TLR4 (8, 9). In
monocyte-derived cells, Neisseria LOS had been implicated in ac-
tivation of two signaling pathways: TLR4 and the caspase-1 acti-
vating NLRP3 inflammasome pathway (4, 25). We now present
data demonstrating that N. gonorrhoeae msbB is required for ro-
bust inflammatory signaling by N. gonorrhoeae. This effect is pri-













































































FIG 5 N. gonorrhoeae msbB is required to induce significant vaginal inflammation in the murine model of gonorrhea. Mice were infected with the indicated N.
gonorrhoeae strain as described in the legend to Fig. 4. Neutrophils and total nucleated cells present on vaginal swabs were enumerated as described in Materials
and Methods, and the relative frequency (mean  standard deviation [SD]) of neutrophils was plotted for each day (A). A plot of relative vaginal neutrophils
against day postinoculation was generated for each infected animal, and the area under the curve was calculated as the neutrophil influx AUC for that animal.
Results from 3 experiments carried out comparing mock infection (n  15) to infection with N. gonorrhoeae strains 1291 (n  11) and 1291-msbB (n  12) (B)
and from 3 experiments comparing mock infection (n  7) and infection with 1291 (n  7), 1291-msbB (n  8), and 1291-msbB;msbB (n  7) (C) are
shown. Statistical analysis comparing the mean values with two-way ANOVA and Bonferroni’s post hoc test for multiple comparisons was carried out; *,
statistically significant difference (P 
 0.05).
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TLR4, with no detectable contribution to NLRP3 inflammasome ac-
tivation.
A functional Tlr4 allele in mice has been shown to be important
in the control of the bacterial load of N. gonorrhoeae in the murine
vaginal infection model (20). Surprisingly, the msbB strain of N.
gonorrhoeae, which has reduced TLR4 activation, does not exhibit
extended persistence or higher loads in the murine model. In fact,
the bacterial load after infection with 1291-msbB was lower on
the day immediately after inoculation (Fig. 4D). The early reduc-
tion in bacterial load seen in the msbB strain appears to be a
phenotype stemming from the penta-acylation of lipid A because
the phenotype is restored in the complemented mutant strain in
which hexa-acylated lipid A is restored. The mechanism underly-
ing these phenotypes may reflect increased susceptibility to host
antimicrobial defenses. The deletion of msbB has been shown to
increase susceptibility to host cell killing, polymyxin, and other
antimicrobial peptides in N. meningitidis as well as other patho-
genic bacteria, including Yersinia and Vibrio species (26–28).
However, if this susceptibility to host factors does play a role in the
initial reduction in bacterial load, it is inadequate to allow clear-
ance of the N. gonorrhoeae inoculum. Deletion of the msbB gene
did not affect the ability of N. gonorrhoeae to persist in the mouse
vaginal infection model or the quantity of bacteria present in the
infected mice over the duration of the infection. It is possible that
because deletion of msbB in N. gonorrhoeae results in reduced
TLR4 stimulation, there are reduced levels of antimicrobial pep-
tides present in mice infected only with 1291-msbB compared to
those infected with a combination of wild-type 1291 and 1291-
msbB. This combination of increased susceptibility to innate de-
fenses and reduced stimulation of host innate immunity afforded
by disruption of msbB could explain the observation that the msbB
mutant N. gonorrhoeae demonstrated a profound fitness deficit in
mixed infection and almost no deficit in single infection. Other
possible explanations exist for the reduced recovery of the msbB
mutant N. gonorrhoeae strain from the murine vaginal cavity 1 day
after inoculation, such as diminished biofilm formation or dimin-
ished epithelial invasion, both of which are known phenotypes of
1291-msbB in ex vivo culture experiments (15, 16). Further stud-
ies are required to better understand the mechanisms that con-
tribute to the initial drop in N. gonorrhoeae bacteria after inocu-
lation in this model.
Paralleling the finding that N. gonorrhoeae strains that lack a
functional msbB induced limited inflammatory signaling in
phagocytic cells, the msbB mutant of N. gonorrhoeae also induces
less vaginal inflammation than its wild-type parental strain in a
murine gonorrhea model. These findings are in line with observa-
tions for the role of msbB in other bacterial pathogens, including
Shigella flexneri and N. meningitidis. In murine and rabbit models
of shigella enteritis, deletion of the two msbB genes and the result-
































































































FIG 6 N. gonorrhoeae msbB controls vaginal cytokine accumulation in the murine model of vaginal infection. Mice were infected with the indicated N.
gonorrhoeae strains as described for Fig. 4. The indicated cytokines, i.e., TNF-	 (A), MIP-1	 (B), and IL-1 (C), were measured in day 4 vaginal lavage fluid as
described in Materials and Methods. (D) Expression levels of host infection response genes in cells from the vaginal swabs of mice infected with 1291,
1291-msbB, and 1291-msbB;msbB were measured using an RT-PCR array as described in Materials and Methods. The relative expressions (normalized to
strain 1291-infected mice) of cxcl2 and naip1 are reported. Statistical analysis with two-way ANOVA and Bonferroni’s post hoc test for multiple comparisons was
carried out; *, statistically significant difference (P 
 0.05); N.S., not significant.
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tion and increased host survival (29). Deletion of lpxL1 (the N.
meningitidis equivalent of N. gonorrhoeae msbB) in N. meningitidis
results in an avirulent meningococcus in a murine bacteremia
model, with rapid bacterial clearance compared to that seen in the
parental N. meningitidis strain (10). The clearance of N. meningi-
tidis lpxL1 is compared with enhanced host survival and a dra-
matic reduction in clinical severity of disease scores. The increased
clearance in this bacteremia model suggests that the protection
against host antimicrobial peptides that is afforded by a hexa-
acylated LOS may be more important for survival in blood than at
the mucosal surface of the vagina, where N. gonorrhoeae msbB
appears able to maintain colonization. Because penta-acylated
LOS is a TLR4 antagonist in human cells and a low-potency ago-
nist in murine cells, the reduced inflammatory response seen in
the murine gonorrhea model in response to msbB-deficient N.
gonorrhoeae may actually be further accentuated in a human in-
fection.
N. gonorrhoeae induces localized inflammation that is respon-
sible for symptoms associated with infection by this bacterium.
However, in one-half of the cases of gonococcal infection of the
female genitourinary tract, patients experience no noticeable
symptoms. The factors that dictate symptomatic infection rather
than asymptomatic infection have yet to be determined. However,
the data we have presented suggest that variations in lipooligosac-
charide structure may play an important role in this phenomenon.
The role of lipid A hexa-acylation directed by msbB in human
disease is of particular interest given the identification of muta-
tions in this gene in another pathogenic Neisseria species, which
are associated with milder disease presentation (12, 13). Though
mutations that eliminate a functional lpxL1 gene (the homolog of
N. gonorrhoeae msbB) in N. meningitidis have been identified in
clinical isolates, these have yet to be identified in N. gonorrhoeae
isolates. No evidence of phase-variable expression has been ob-
served in N. gonorrhoeae msbB in in vitro culture. However, the
gene does contain a homopolymeric tract of six thymidine resi-
dues nine bases downstream of the initiating methionine codon
that could potentially be a site for slipped strand mispairing. Such
mispairing would lead to phase-variable expression of msbB by
placing the gene out of frame. Phase-variable expression in Neis-
seria species is more often associated with longer homopolymeric
runs of guanine bases, but there is one report of phase variation
resulting from a polyadenine tract in the promoter of the porA
gene in N. meningitidis (30). Recent studies have also found asso-
ciations between lipid A phosphorylation, diphosphorylation, and
phosphotidyl ethanolamine (PEA) decoration and the potency of
TLR4 activation and host inflammatory cytokine production (25,
31–33). Interestingly, PEA decoration is carried out by an enzyme
(LptA) that is encoded in the genomes of both pathogenic Neisse-
riaceae but not the commensal Neisseriaceae. As reported by John
et al., for N. meningitidis, we have found that LOS from N. gonor-
rhoeae that lacks lptA also has reduced potency in TLR4 activation
and host inflammatory cytokine induction (32; X. Zhou and J. A.
Duncan, data not shown). Like hexa-acylation of lipid A, PEA
decoration has also been shown to afford resistance to host anti-
microbial peptides (34, 35). Combined with the data we have pre-
sented on the activity of penta-acylated LOS from N. gonorrhoeae
with disrupted msbB, these findings all suggest that the host may
create a selective pressure for the maintenance of a proinflamma-
tory lipid A; however, this hypothesis requires further evaluation.
Additionally, a detailed examination of the lipid A structure from
gonococcal clinical isolates may demonstrate that alterations of
multiple pathways in lipid A biosynthesis may contribute to the
development of symptomatic and asymptomatic N. gonorrhoeae
infections.
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